Where BioCardia Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on BioCardia (NASDAQ:BCDA) stock, all of them being bullish. The average price target is $6.5, implying significant upside from the current price of $0.3976. However, this average has decreased by 27.78% from the previous average price target of $9.00.

October 11, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on BioCardia (NASDAQ:BCDA) with a significant upside predicted. However, the average price target has decreased by 27.78%.
The unanimous bullish sentiment among analysts and the significant implied upside from the current price could drive the stock price up in the short term. However, the decrease in the average price target might temper the bullish sentiment to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100